Skip to main content
NIH funding notice PAR-22-239

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)

Closed on January 6, 2023.

Posted
October 26, 2022
Close date
January 6, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $585,686 in first-year total cost, median $292,843.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-2 (A1)]2

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. TEXAS SOUTHERN UNIVERSITY1
Competing awards under PAR-22-239 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
20231/2 Collaborative Union for Cancer Research, Education and Disparities (CURED)1P20CA284971-01AJEWOLE, VERONICA B.ROUCE, RAYNE HELENBAYLOR COLLEGE OF MEDICINE, TX$300,123ZCA1
20232/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)1P20CA284967-01AJEWOLE, VERONICA B.ROUCE, RAYNE HELENTEXAS SOUTHERN UNIVERSITY, TX$285,563ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-22-239: Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) | ScienceDex | ConductScience